VVMF, Australia's First Viral Vector CDMO Receives TGA Manufacturing Licence

SYDNEY, Sept 10 (Bernama) -- Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first viral vector Contract Development and Manufacturing Organisation (CDMO) advises that the Therapeutic Goods Administration (TGA) has granted the company a Licence to Manufacture Therapeutic Goods (GMP licence) for the Sydney facility.

This milestone is significant for Australia's rapidly growing cell and gene therapy sector, enabling VVMF to manufacture viral vectors under GMP conditions to support the development and commercialisation of advanced therapeutic products for Australian and Global clients.